» Articles » PMID: 40072108

Decreased Expression of Aquaporins As a Feature of Tubular Damage in Lupus Nephritis

Abstract

Tubulointerstitial hypoxia is a key factor for lupus nephritis progression to end-stage renal disease. Numerous aquaporins (AQPs) are expressed by renal tubules and are essential for their proper functioning. The aim of this study is to characterize the tubular expression of AQP1, AQP2 and AQP3, which could provide a better understanding of tubulointerstitial stress during lupus nephritis. This retrospective monocentric study was conducted at Erasme-HUB Hospital. We included 37 lupus nephritis samples and 9 healthy samples collected between 2000 and 2020, obtained from the pathology department. Immunohistochemistry was performed to target AQP1, AQP2 and AQP3 and followed by digital analysis. No difference in AQP1, AQP2 and AQP3 staining location was found between healthy and lupus nephritis samples. However, we observed significant differences between these two groups, with a decrease in AQP1 expression in the renal cortex and in AQP3 expression in the cortex and medulla. In the subgroup of proliferative glomerulonephritis (class III/IV), this decrease in AQPs expression was more pronounced, particularly for AQP3. In addition, within this subgroup, we detected lower AQP2 expression in patients with higher interstitial inflammation score and lower AQP3 expression when higher interstitial fibrosis and tubular atrophy were present. We identified significant differences in the expression of aquaporins 1, 2, and 3 in patients with lupus nephritis. These findings strongly suggest that decreased AQP expression could serve as an indicator of tubular injury. Further research is warranted to evaluate AQP1, AQP2, and AQP3 as prognostic markers in both urinary and histological assessments of lupus nephritis.

References
1.
Matsuzaki T, Yaguchi T, Shimizu K, Kita A, Ishibashi K, Takata K . The distribution and function of aquaporins in the kidney: resolved and unresolved questions. Anat Sci Int. 2016; 92(2):187-199. DOI: 10.1007/s12565-016-0325-2. View

2.
Wang Y, Zhang W, Yu G, Liu Q, Jin Y . Cytoprotective effect of aquaporin 1 against lipopolysaccharide-induced apoptosis and inflammation of renal epithelial HK-2 cells. Exp Ther Med. 2018; 15(5):4243-4252. PMC: 5920784. DOI: 10.3892/etm.2018.5992. View

3.
Preisser L, Teillet L, Aliotti S, Gobin R, Berthonaud V, Chevalier J . Downregulation of aquaporin-2 and -3 in aging kidney is independent of V(2) vasopressin receptor. Am J Physiol Renal Physiol. 2000; 279(1):F144-52. DOI: 10.1152/ajprenal.2000.279.1.F144. View

4.
Lei L, Wang W, Jia Y, Su L, Zhou H, Verkman A . Aquaporin-3 deletion in mice results in renal collecting duct abnormalities and worsens ischemia-reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(6):1231-1241. DOI: 10.1016/j.bbadis.2017.03.012. View

5.
Meli R, Pirozzi C, Pelagalli A . New Perspectives on the Potential Role of Aquaporins (AQPs) in the Physiology of Inflammation. Front Physiol. 2018; 9:101. PMC: 5820367. DOI: 10.3389/fphys.2018.00101. View